ABT Stock Chart & Stats
C$18.96
C$0.11(0.58%)
At close: 4:00 PM EDT
C$18.96
C$0.11(0.58%)
Day’s Range― - ―
52-Week RangeC$14.46 - C$22.79
Previous CloseN/A
Volume4.48K
Average Volume (3M)15.88K
Market Cap
C$253.76B
Enterprise ValueC$67.04B
Total Cash (Recent Filing)C$58.24M
Total Debt (Recent Filing)C$9.83M
Price to Earnings (P/E)33.5
Beta0.45
Next Earnings
Oct 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.42%
Share Statistics
EPS (TTM)0.22
Shares Outstanding1,730,383,300
10 Day Avg. Volume9,575
30 Day Avg. Volume15,876
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged News
ABT FAQ
What was Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s price range in the past 12 months?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged lowest stock price was C$14.46 and its highest was C$22.79 in the past 12 months.
What is Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s market cap?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s market cap is C$253.76B.
When is Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s upcoming earnings report date?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s upcoming earnings report date is Oct 21, 2026 which is tomorrow.
How were Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s earnings last quarter?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged released its earnings results on Jul 16, 2026. The company reported C$0.737 earnings per share for the quarter.
Is Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged overvalued?
According to Wall Street analysts Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s price is currently Overvalued.
Does Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged pay dividends?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged pays a Quarterly dividend of C$0.11 which represents an annual dividend yield of 2.42%. See more information on Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged dividends here
What is Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s EPS estimate?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged have?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has 1,730,383,300 shares outstanding.
What happened to Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s price movement after its last earnings report?
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged reported an EPS of C$0.737 in its last earnings report. Following the earnings report the stock price went up 10.029%.
Which hedge fund is a major shareholder of Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged?
Currently, no hedge funds are holding shares in TSE:ABT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (ABT) Earnings & Revenues
Technical Analysis
Arch Biopartners
―
Biosyent
―
Procter & Gamble Company Shs Sponsored canadian Depositary Receipt Repr Sh
―